Track the Micro-X Limited stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, Micro-X Limited has logged 5 insider filings. Market capitalisation: €20.2m. The latest transaction was reported on 6 August 2026 (Change in Substantial Holding). Among the most active insiders: 5 August 2026. All data is openly available.
Analysts rate Micro-X Limited Strong Buy (bullish), based on 1 analysts. Average price target: A$0.08.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Micro-X Limited is a company focused on developing medical imaging technologies. It specializes in creating portable and innovative imaging systems for the healthcare sector.